Predictions
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€372.60
04.05.24
04.05.24
-
04.05.25
04.05.25
-
03.05.24
03.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-5.94%
03.05.24
03.05.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.10
01.05.24
01.05.24
-
01.05.25
01.05.25
-0.55%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€842.40
01.05.25
01.05.25
-5.94%
03.05.24
03.05.24
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€60.80
01.05.24
01.05.24
€79.54
01.05.25
01.05.25
-1.02%
03.05.24
03.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€834.73
01.05.25
01.05.25
-5.94%
03.05.24
03.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€732.70
30.04.24
30.04.24
€828.45
30.04.25
30.04.25
-6.71%
03.05.24
03.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€835.40
30.04.24
30.04.24
-
30.04.25
30.04.25
6.44%
03.05.24
03.05.24
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
28.04.24
28.04.24
-
28.04.25
28.04.25
3.99%
03.05.24
03.05.24
Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
3.99%
03.05.24
03.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€61.35
26.04.24
26.04.24
€79.45
26.04.25
26.04.25
-1.91%
03.05.24
03.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
1.30%
03.05.24
03.05.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€122.60
26.04.24
26.04.24
€133.79
26.04.25
26.04.25
-3.26%
03.05.24
03.05.24